Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice

Journal of Pathology

Volumn 210, Issue 3, 2006, Pages 298-305

  Aly, S ^a   Wagner, K ^b   Keller, C ^a   Malm, S ^c   Malzan, A ^a   Brandau, S ^a   Bange, F C ^c   Ehlers, S ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Animal model; Granuloma; Hypoxia; Necrosis; Persistence; Tuberculosis

Indexed keywords

NITRATE REDUCTASE; OXYGEN; PIMONIDAZOLE;

ANAEROBIC CAPACITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM MUTANT; CHRONICITY; CONTROLLED STUDY; DISEASE MODEL; DRUG RESEARCH; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LATENT PERIOD; LUNG GRANULOMA; LUNG TUBERCULOSIS; MALE; MICROELECTRODE; MOUSE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXYGEN TENSION; PATHOGENESIS; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ANOXIA; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ELECTRODES; FEMALE; GRANULOMA; IMMUNOHISTOCHEMISTRY; LUNG; MICE; MICE, INBRED C57BL; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; NITRATES; NITROIMIDAZOLES; OXYGEN; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 33750503812     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2055     Document Type: Article

References (51)

1. Maher D, Raviglione M. Global epidemiology of tuberculosis. Clin Chest Med 2005;26:167-82.
2. Chan J, Flynn J. The immunological aspects of latency in tuberculosis. Clin Immunol 2004;110:2-12.
3. Stewart GR, Robertson BD, Young DB. Tuberculosis: a problem with persistence. Nat Rev Microbiol 2003;1:97-105.
4. Boshoff HI, Barry CE, III. Tuberculosis - metabolism and respiration in the absence of growth. Nat Rev Microbiol 2005;3:70-80.
5. Wayne LG. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur J Clin Microbiol Infect Dis 1994;13:908-914.
6. Zhang Y. Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci 2004;9:1136-1156.
7. Chiang CY, Riley LW. Exogenous reinfection in tuberculosis. Lancet Infect Dis 2005;5:629-636.
8. Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 2003;3:578-590.
9. Dannenberg AM, Rook GAW. Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses - dual mechanisms that control bacillary multiplication. In Tuberculosis: Pathogenesis, Protection and Control, Bloom BR (ed). ASM Press: Washington, DC, 1994; 459-483.
10. Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun 1996;64:2062-2069.
11. McKinney JD, Honer zu BK, Munoz-Elias EJ, Miczak A, Chen B, Chan WT, et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000;406:735-738.
12. Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004;431:84-87.
13. Orme IM. The mouse as a useful model of tuberculosis. Tuberculosis (Edinb) 2003;83:112-115.
14. North RJ, Jung YJ. Immunity to tuberculosis. Annu Rev Immunol 2004;22:599-623.
15. Rosenthal IM, Williams K, Tyagi S, Vernon AA, Peloquin CA, Bishai WR, et al. Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis. Am J Respir Crit Care Med 2005;172:1457-1462.
16. Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber Lung Dis 1997;78:57-66.
17. North RJ. Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route. J Infect Dis 1995;172:1550-1553.
18. Benini J, Ehlers EM, Ehlers S. Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium. J Pathol 1999;189:127-137.
19. Samoszuk MK, Walter J, Mechetner E. Improved immunohistochemical method for detecting hypoxia gradients in mouse tissues and tumors. J Histochem Cytochem 2004;52:837-839.
20. Odman S, Lund N. Data acquisition and information processing in MDO oxygen electrode measurement of tissue oxygen pressure. Acta Anaesthesiol Scand 1980;24:161-165.
21. Hoelper BM, Alessandri B, Heimann A, Behr R, Kempski O. Brain oxygen monitoring: in-vitro accuracy, long-term drift and response-time of Licox- and Neurotrend sensors. Acta Neurochir (Wien) 2005;147:767-774.
22. Schreiber T, Ehlers S, Aly S, Holscher A, Hartmann S, Lipp M, et al. Selectin ligand-independent priming and maintenance of T cell immunity during airborne tuberculosis. J Immunol 2006;176:1131-1140.
23. Stermann M, Bohrssen A, Diephaus C, Maass S, Bange FC. Polymorphic nucleotide within the promoter of nitrate reductase (NarGHJI) is specific for Mycobacterium tuberculosis. J Clin Microbiol 2003;41:3252-3259.
24. Ehlers S, Benini J, Held HD, Roeck C, Alber G, Uhlig S. αβTCR + cells and IFNγ, but not iNOS, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J Exp Med 2001;194:1847-1859.
25. Bohle A, Brandau S. Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer. J Urol 2003;170:964-969.
26. Morgan SM, Samulowitz U, Darley L, Simmons DL, Vestweber D. Biochemical characterization and molecular cloning of a novel endothelial-specific sialomucin. Blood 1999;93:165-175.
27. Bishai WR, Dannenberg AM Jr, Parrish N, Ruiz R, Chen P, Zook BC, et al. Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method. Infect Immun 1999;67:4931-4934.
28. Gomez JE, McKinney JD. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 2004;84:29-44.
29. Voskuil MI. Mycobacterium tuberculosis gene expression during environmental conditions associated with latency. Tuberculosis (Edinb) 2004;84:138-143.
30. Rodriguez GM, Smith I. Mechanisms of iron regulation in mycobacteria: role in physiology and virulence. Mol Microbiol 2003;47:1485-1494.
31. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 2002;43:717-731.
32. Primm TP, Andersen SJ, Mizrabi V, Avarbock D, Rubin H, Barry CE III. The stringent response of Mycobacterium tuberculosis is required for long-term survival. J Bacteriol 2000;182:4889-4898.
33. Wayne LG, Sohaskey CD. Nonreplicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol 2001;55:139-63.
34. Park HD, Guinn KM, Harrell MI, Liao R, Voskuil MI, Tompa M, et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol 2003;48:833-843.
35. Ohno H, Zhu G, Mohan VP, Chu D, Kohno S, Jacobs WR Jr, et al. The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis. Cell Microbiol 2003;5:637-648.
36. Glickman MS, Jacobs WR Jr. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 2001;104:477-485.
37. Rodriguez GM, Voskuil MI, Gold B, Schoolnik GK, Smith I. ideR, an essential gene in Mycobacterium tuberculosis: role of ideR in iron-dependent gene expression, iron metabolism, and oxidative stress response. Infect Immun 2002;70:3371-3381.
38. Dahl JL, Kraus CN, Boshoff HI, Doan B, Foley K, Avarbock D, et al. The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc Natl Acad Sci USA 2003;100:10026-10031.
39. Hu Y, Movahedzadeh F, Stoker NG, Coates AR. Deletion of the Mycobacterium tuberculosis (alpha)-crystallin-like hspX gene causes increased bacterial growth in vivo. Infect Immun 2006;74:861-868.
40. Parish T, Smith DA, Kendall S, Casali N, Bancroft GJ, Stoker NG. Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis, Infect Immun 2003;71:1134-1140.
41. Malhotra V, Sharma D, Ramanathan VD, Shakila H, Saini DK, Chakravorty S, et al. Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis. FEMS Microbiol Lett 2004;231:237-245.
42. Munoz-Elias EJ, McKinney JD. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med 2005;11:638-644.
43. Sohaskey CD, Wayne LG. Role of narK2X and narGHJI in hypoxic upregulation of nitrate reduction by Mycobacterium tuberculosis. J Bacteriol 2003;185:7247-7256.
44. Brown JM. Keynote address: hypoxic cell radiosensitizers: where next? Int J Radiat Oncol Biol Phys 1989;16:987-993.
45. Arteel GE, Thurman RG, Yates JM, Raleigh JA. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer 1995;72:889-895.
46. Arteel GE, Thurman RG, Raleigh JA. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem 1998;253:743-750.
47. Tsai MC, Chakravarty S, Zhu G, Xu J, Tanaka K, Koch C, et al. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 2006;8:218-232.
48. Wayne LG, Sramek HA. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1994;38:2054-2058.
49. Cooper AM, Callahan JE, Keen M, Belisle JT, Orme IM. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tuber Lung Dis 1997;78:67-73.
50. Jung YJ, Ryan L, LaCourse R, North RJ. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2005;201:1915-1924.
51. Brooks JV, Furney SK, Orme IM. Metronidazole therapy in mice infected with tuberculosis. Antimicrob Agents Chemother 1999;43:1285-1288.